Hope for Patients with Solitary Fibrous Tumor: Advances in Sarcoma Care With Dr. Robin Jones

Dr. Peter Crane interviews leading sarcoma oncologist Professor Robin Jones on the evolution of solitary fibrous tumor diagnosis and treatment, from molecular insights to promising new targeted therapies. Essential listening for patients, oncologists, and researchers navigating rare sarcomas. ⏱️ Timestamps: 00:00 – Introduction and welcome 01:00 – Dr. Jones’ career journey (UK , Seattle, Royal Marsden) 07:00 – Understanding the rarity and heterogeneity of sarcomas 08:00 – NAB2/STAT6 fusion and improved SFT diagnosis 12:00 – FAP-directed therapies (doxorubicin & radioligands) 16:00 – Anti-angiogenic agents (pazopanib, bevacizumab, cabozantinib) 18:00 – Drug access challenges in the UK NHS 22:00 – Funding rare cancer research and clinical trials 26:00 – When to consider clinical trials in metastatic disease 30:00 – Importance of tissue donation and biobanks 31:00 – Closing thoughts and where to follow Dr. Jones 🔗 Resources Mentioned Royal Marsden Sarcoma Unit Dr. Robin Jones on X: @robinl_jones 👍 If this episode helped you, please like, subscribe, and share. It helps these conversations reach the physicians who need them most. #DoctorsMakingADifference #Sarcoma #SolitaryFibrousTumor #RareCancer #PrecisionOncology #ClinicalTrials #FAPTherapy #SarcomaResearch #PhysicianPodcast